Cargando…
Weekly oral alendronate in mevalonate kinase deficiency
BACKGROUND: Mevalonate kinase deficiency (MKD) is caused by mutations in the MVK gene, encoding the second enzyme of mevalonate pathway, which results in subsequent shortage of downstream compounds, and starts in childhood with febrile attacks, skin, joint, and gastrointestinal symptoms, sometimes i...
Autores principales: | Cantarini, Luca, Vitale, Antonio, Magnotti, Flora, Lucherini, Orso Maria, Caso, Francesco, Frediani, Bruno, Galeazzi, Mauro, Rigante, Donato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880037/ https://www.ncbi.nlm.nih.gov/pubmed/24360083 http://dx.doi.org/10.1186/1750-1172-8-196 |
Ejemplares similares
-
Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013) -
Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues
por: Caso, Francesco, et al.
Publicado: (2013) -
From the Mediterranean to the Sea of Japan: The Transcontinental Odyssey of Autoinflammatory Diseases
por: Rigante, Donato, et al.
Publicado: (2013) -
Caution Should be Used in the Recognition of Adult-Onset Autoinflammatory Disorders: Facts or Fiction?
por: Cantarini, Luca, et al.
Publicado: (2013) -
Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
por: Caso, Francesco, et al.
Publicado: (2014)